bluebird bio Inc ASH Data Review Conference Call Transcript
Good evening, everyone. My name is Jeff, and I will be your conference operator today. At this time, I would like to welcome everyone to the bluebird bio ASH Data Review Webcast 2020. (Operator Instructions)
Thank you. I would now like to turn the call over to Ms. Ingrid Goldberg, Vice President of Investor Relations. You may begin your conference.
Thank you, Jeff. Good evening, and thank you for joining bluebird bio's 2020 ASH Conference Call. The agenda for today's call is as follows. First, Nick will make opening remarks and then turn the call over to Rich Colvin, Head of Severe Genetic Disease Clinical Research, who will review multiple weekend presentations and the data on TDT and sickle cell disease.
Next, we'll give you Niculescu, Head of Clinical Development for Multi Myeloma, who will discuss our CRB-401 update; and Philip Gregory, Chief Scientific Officer, will close with CRB-402 for bb21217. Nick will then complete our prepared remarks before joining -- being joined by both Chip Baird
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |